The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer

Aim: We explore the biomarker potential of the TERT hypermethylated oncologic region (THOR) in pancreatic cancer. Materials & methods: We assessed the methylation status of THOR using the cancer genome atlas data on the cohort of pancreatic cancer (n = 193 patients). Results: THOR was significan...

Full description

Bibliographic Details
Main Author: Faleiro, Inês (author)
Other Authors: Apolónio, Joana (author), Price, Aryeh J. (author), De Mello, Ramon Andrade (author), Roberto, Vânia (author), Tabori, Uri (author), Castelo-Branco, Pedro (author)
Format: article
Language:eng
Published: 2019
Subjects:
Telomerase
Expression
Carcinoma
Online Access:http://hdl.handle.net/10400.1/12962
Country:Portugal
Oai:oai:sapientia.ualg.pt:10400.1/12962

Internet

http://hdl.handle.net/10400.1/12962

Similar Items